A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
{ "Study of MT1 Algorithm for ADHD Diagnosis in Youth", "This study is looking for young people aged 6 to 17 with ADHD to test a new way to help doctors diagnose ADHD. It compares a new device called the MT1 Auditory startle response patterns analysis algorithm with a standard test called the T.O.V.A. Continuous Performance Test. The goal is to see how well the MT1 algorithm matches a diagnosis made by ADHD specialists. We want to see if the MT1 algorithm is as good as or better than the T.O.V.A. test in helping doctors diagnose ADHD. The study plans to enroll 120 participants. If you or your child are taking stimulant medication, you would need to stop it for about 3 days before testing.", "design": "This interventional study plans to enroll 120 participants. It compares a new diagnostic algorithm (MT1) to a standard diagnostic test (T.O.V.A.) and specialist diagnoses.", "commitments": "You would need to be available for clinical assessment and testing with biometric and performance devices, which is expected to take approximately 1-2 days. If taking stimulants, you would need to stop them for about 3 days prior to testing.", "compensation": "Not stated in the trial record.", "follow_up": "The primary outcome is measured from the beginning of clinical assessment until the end of testing, which is approximately 1-2 days.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jeffrey Newcorn, MD Professor · PRINCIPAL_INVESTIGATOR · Director, Division of ADHD and Learning Disorders Icahn School of Medicine at Mount Sinai
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Overall Agreement Rate (OAR) - probability that the test will be normal and the condition is normal or positive and the condition is positive, out of all subjects.From the beginning of clinical assessment until the end of testing (approximately 1-2 days).
The outcome measure will be calculated by using the following formula: Over All Agreement = (True Positive + True Negative) / (True Positive + True Negative + False Positive + False Negative) X 100.